Hereditary Renal Cell Carcinoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
8
|
2
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Serrated adenocarcinoma
|
disease |
|
Neoplastic Process
|
11
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Deep endometriosis
|
disease |
Digestive System Diseases; Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Skin sensitisation
|
disease |
|
Disease or Syndrome
|
34
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Obesity-Associated Insulin Resistance
|
disease |
|
Disease or Syndrome
|
36
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Contact hypersensitivity
|
phenotype |
Skin and Connective Tissue Diseases
|
Pathologic Function
|
71
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Chemical Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
71
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Skin Diseases, Infectious
|
group |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
74
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Recurrent skin infections
|
phenotype |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
95
|
2
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Chronic granulomatous disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
105
|
23
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Contact Dermatitis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
110
|
3
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Organic Mental Disorders, Substance-Induced
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Prescription Drug Abuse
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Finding
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
121
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
128
|
20
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
156
|
19
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Melanoma, B16
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
157
|
1
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Oral Cavity Carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
167
|
16
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Inflammatory Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
183
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Substance abuse problem
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
185
|
20
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
High grade glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
190
|
15
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
196
|
19
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
218
|
16
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
MRSA - Methicillin resistant Staphylococcus aureus infection
|
disease |
Infections
|
Disease or Syndrome
|
222
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinoma, Endometrioid
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
223
|
12
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |